Experimental allergen-specific immunotherapy under the umbrella of JAK1/3 pathway inhibition substantial improved local parameters of allergic airway inflammation.
Allergy71, 507-507 (2016)
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.